DEVELOPING UNIQUE Allosteric modulators of integrins for cancer:
The dimmer switch analogy
AVIPERO has unique Platform technology with multiple applications/indications.
AVIPERO Bio is led by strong team with track record in drug development in cancer. At Avipero we aspire to revolutionize the treatment of malignant and degenerative diseases worldwide. We are dedicated to the study of advanced cancer, our pharmaceutical research company prioritizes the development of a non-destructive cure for this metastatic disease.
Company Details
- Employees
- 4
- Founded
- 2023
- Address
- Wilmington, Delaware, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://avipero.com/
- HQ
- Wilmington, Delaware
Avipero Bio Questions
Avipero Bio's website is https://avipero.com/
Avipero Bio's LinkedIn profile is https://www.linkedin.com/company/avipero-bio
Avipero Bio has
4 employees.
View email and phone details for 4
employees at Avipero Bio.
Avipero Bio's industry is
Biotechnology Research
Avipero Bio's top competitors are
Arionix Therapeutics Inc.,
N4 Pharma Plc,
Cambridgeshire Bathrooms Ltd,
Excellergy,
Wits School Of Public Health,
Chromatin Bioscience,
Avergen Pharmaceuticals Gmbh,
Avicenna Biosciences, Inc.,
Aten Therapeutics Ltd,
Avipero.
Avipero Bio's categories are Biotechnology Research
Avipero Bio's founding year is 2023
